Cord Blood Cell-Free DNA Concentration: A Novel Marker for Neonatal Wellbeing
American Journal of Perinatology · 01.06.2024 · 41 (08) · 1027-1032
DOI: 10.1055/a-1787-3838 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Perinatology, erschienen am 01.06.2024. Verfasst von Majdi Imterat und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Bee…. Hauptthemen laut MEDLINE: Cell-Free Nucleic Acids, Fetal Blood, Biomarkers. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Objective
Cord gas values and Apgar scores, currently used as markers for newborn wellbeing and postpartum complications, provide rough estimates, and their use remains elusive. Circulating cell-free DNA (cfDNA) may better represent newborn status at birth and the effect of parturition on the fetus. This pilot study investigates the association between cord blood (CB) cfDNA and neonatal outcomes. Study Design In a prospective cohort study, cfDNA concentration was measured in immediately following delivery collected CB sera of newborns using our rapid fluorescent assay.
Results
During the study period, blood samples from umbilical cords of 100 newborns were collected. Vaginal delivery was associated with a higher median CB cfDNA than cesarean delivery (277 [95% confidence interval [CI] 199–377] vs. 100 [95% CI 43–265] ng/mL, p < 0.01). cfDNA levels were significantly associated with gestational age at delivery (rho = 0.308, p = 0.002) and CB base deficit (BD, r = 0.252, p = 0.017). According to maternal and fetal complications, CB cfDNA was elevated in fetuses with category II of heart rate tracing (p < 0.05), with maternal positive vaginal culture (p < 0.01), and with premature rupture of membranes (PROM, p < 0.001). Logistic regression models of CB cfDNA fourth quartiles demostrate a double odds ratio for elevated BD (>3mmol/L) and for worse heart rate tracing category.
Conclusion
Serum CB cfDNA concentration reflects the newborn's status and hazards with an excellent association with CB BD, fetal heart rate category, and maternal risk factors for infection (positive vaginal culture and PROM). This preliminary observation suggests that cfDNA can serve as a point of care biomarker for newborn status at the time of delivery. Key Points
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
- Department of Gynecology and Gynecologic Oncology, Ev. Kliniken Essen-Mitte, Essen, Germany.
- Department of Obstetrics and Gynecology, HaEmek Medical Center, Afula, Israel.
- Department of Obstetrics and Gynecology, Wayne State University School of Medicine, Detroit, Michigan.
- Department of Life Sciences, Faculty of Natural Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
- Department of Clinical Biochemistry and Pharmacology, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
ORCID-Profile: Majdi Imterat
Zitieren
APA
Imterat, M., Erez, O., Tirosh, D., Gelkop, Y. M., Benshalom-Tirosh, N., Ben-Tabo, M., & Douvdevani, A. (2024). Cord Blood Cell-Free DNA Concentration: A Novel Marker for Neonatal Wellbeing. American Journal of Perinatology, 41(08), 1027-1032. https://doi.org/10.1055/a-1787-3838
Vancouver
Imterat M, Erez O, Tirosh D, Gelkop YM, Benshalom-Tirosh N, Ben-Tabo M, et al. Cord Blood Cell-Free DNA Concentration: A Novel Marker for Neonatal Wellbeing. American Journal of Perinatology. 2024;41(08):1027-1032. doi:10.1055/a-1787-3838
BibTeX
@article{Imterat2024,
author = {Imterat, Majdi and Erez, Offer and Tirosh, Dan and Gelkop, Yael Miller and Benshalom-Tirosh, Neta and Ben-Tabo, Maor and Douvdevani, Amos},
title = {Cord Blood Cell-Free DNA Concentration: A Novel Marker for Neonatal Wellbeing},
journal = {American Journal of Perinatology},
year = {2024},
volume = {41},
number = {08},
pages = {1027--1032},
doi = {10.1055/a-1787-3838}
}
EUVIMED